{{Rsnum
|rsid=16958477
|Gene=LOXL1
|Chromosome=15
|position=73926125
|Orientation=plus
|GMAF=0.2608
|Gene_s=RNASEH2B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 40.7 | 41.6 | 17.7
| HCB | 83.9 | 15.3 | 0.7
| JPT | 77.0 | 20.4 | 2.7
| YRI | 78.9 | 19.7 | 1.4
| ASW | 73.7 | 22.8 | 3.5
| CHB | 83.9 | 15.3 | 0.7
| CHD | 83.5 | 16.5 | 0.0
| GIH | 68.3 | 29.7 | 2.0
| LWK | 90.0 | 9.1 | 0.9
| MEX | 41.4 | 41.4 | 17.2
| MKK | 83.3 | 16.0 | 0.6
| TSI | 36.3 | 47.1 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21212179
|Title=LOXL1 promoter haplotypes are associated with exfoliation syndrome in a US Caucasian population
|OA=1
}}

{{PMID Auto
|PMID=20431720
|Title=Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}